STOCK TITAN

Oncoinvent ASA (BRRGD) Stock Price, News & Analysis

BRRGD OTC
Published by Stock Titan Data refreshed

What Changed

Company Description

This page collects what Stock Titan holds for BRRGD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-
Performance 1 year

Latest News

—

BerGenBio Appoints Olav Hellebø as CEO

management

Oncoinvent ASA has 1 recent news article. Key topics include management. View all BRRGD news →

SEC Filings

No SEC filings available for BRRGD.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Oncoinvent ASA (BRRGD) currently stands at 100 shares, down 75.0% from the previous reporting period, representing 0.0% of the float. Since January 2026, short interest has decreased by 75.0%.

Days to Cover History

Last 12 Months

Days to cover for Oncoinvent ASA (BRRGD) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume.